Newsroom

News

The Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) is supporting the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg - an institution of the Helmholtz Centre for Infection Research Braunschweig in cooperation with the Julius-Maximilians-University - with up to 733,000 euros. The grant is awarded to Daphne Collias, a post-doc in Chase Beisel’s lab at HIRI, to take the new and award-winning LEOPARD technology a decisive step further towards commercialization. In the future, LEOPARD may help physicians and patients by providing more comprehensive diagnostic information about a patient’s health. The funding is part of the "GO-Bio initial" program from the BMBF and is granted for a period of 24 months.

03.11.2021

HIRI

Mikroskopieaufnahme einer Infektionsstelle von Leishmania major in der Haut

News

Nitric oxide (NO) occurs naturally in the human body as a messenger substance. It is considered an all-rounder, as it performs numerous important regulatory functions, including immune defense against pathogens. The exact mode of action of this molecule has now been uncovered by immunologist Prof Andreas Müller from the Institute of Molecular and Clinical Immunology at the University Medical Center Magdeburg together with scientists from the Helmholtz Centre for Infection Research (HZI) in Braunschweig. The findings are crucial for the development of new therapeutic approaches for the treatment of infectious diseases, but also of diseases caused by excessive inflammation. The results were published in the renowned journal "Immunity".

25.10.2021

HZI Campus

BRICS

News

The German Center for Infection Research (DZIF) and the Helmholtz Centre for Infection Research (HZI) have developed a concept to form a National Alliance for Pandemic Therapeutics (NA-PATH). They thereby wish to target research and development of widely effective therapeutics in order to be better prepared for future outbreaks due to viral pathogens having pandemic potential. Overcoming the current COVID-19 pandemic will be considerably more difficult due to the deficiency of antiviral active substances.

06.10.2021

HZI Campus

Raserelektronenmikroskopische Aufnahme von Klebsiella pneumoniae

News

04.10.2021

HZI Campus

Story

The Helmholtz Institute for One Health is a new HZI location in Greifswald, linking research into human and animal health with environmental factors.

04.10.2021

HIOH

News

It often takes many years before a new active compound from basic research hits the market as a drug. In order to accelerate this process, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Saarland University will work together even more closely in the future. To this end, they have now founded the Translational Centre for Bioactive Compounds, in which scientists from both institutions will interact closely with the University Hospital in Homburg and the pharmaceutical industry.

02.10.2021

HIPS

Back to the first page
...
41
42
43
44
...
141

HZI in the media

... außerhalb des Magen-Darm-Traktes zu überleben. Das Helmholtz Zentrum für Infektionsforschung (HZI) bezeichnet die Clostridien als „ ...

12.05.2025

Frankfurter Rundschau online

Maximilians-Universität (JMU) Würzburg und des Würzburger Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) haben 2020 eine ...

11.05.2025

Medizin Aspekte

Im Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) in Saarbrücken wird Spitzenforschung betrieben. Jetzt bekommt ...

09.05.2025

Tagesschau

JMU) Würzburg, in cooperation with the Helmholtz Institute for RNA-based Infection Research (HIRI), have developed and refined a cutting-

08.05.2025

Bioengineer.org

In the “Microbelix” project from the Helmholtz Institute for Pharmaceutical Research in Saarland, citizens can send soil samples from

08.05.2025

techzle

triggers of future pandemics. A research team from the Helmholtz Center for Infection Research (HZI) and the Medical Center—University of

07.05.2025

Phys.org